Clinical Development Medical Director (CDMD) Neuroscience

Novartis

3d•Hybrid

About The Position

The Clinical Development Medical Director (CDMD) is the Global clinical leader of defined and assigned program level activities and deliverables (e.g. submission activities, briefing books etc.), or clinical trial(s), under the leadership of the GPCH or Sr CDMD.

Requirements

MD or equivalent medical degree required.
Advanced knowledge and clinical training in a medical/scientific area (e.g., internal medicine or sub-specialty) required, with Medical Board certification preferred
Clinical practice experience ≥ 4 years (including residency) preferred
≥ 5 years of involvement in clinical research or global drug development in an academic or industry environment spanning clinical activities in Phases I through IV.
≥ 3 years of contribution to and accomplishment in all aspects of conducting clinical trials (e.g., planning, executing, reporting and publishing) in a global/matrix environment in pharmaceutical industry.
Experience in late phase clinical development preferred
Solid and advanced scientific acumen and ability to analyze and interpret scientific literature and data
Advanced knowledge of assigned therapeutic area
Demonstrated ability to establish strong scientific partnership with key stakeholders
Thorough knowledge of ICH, GCP, clinical trial design and methodology, statistical analysis methodology, and regulatory/ clinical development process
1 year or more of people management experience required, this may include management in a matrix environment.
Global people management experience desirable
Experience with operating and delivering in a complex global matrix environment. and excellent team player
Excellent communication skills, written and oral
Excellent interpersonal skills
Excellent negotiation and conflict resolution skills

Responsibilities

Provides clinical leadership, scientific and medical strategic input for all clinical deliverables in the assigned or defined program activities as applicable. Clinical deliverables may include (sections of) individual protocols consistent with the Integrated Development Plans (IDP) and CDP, clinical data review, program specific standards, clinical components of regulatory documents/registration dossiers, and publications
Leads development of clinical sections of trial and program level regulatory documents (e.g., Investigator’s Brochures, briefing books, safety updates, submission dossiers, and responses to Health Authorities)
Drives execution of the section of the clinical program in partnership with global line functions, assigned Clinical Trial Heads (CTHs), and regional/country medical associates if applicable
Provides medical oversight and leadership of trials and may act as medical monitor. Provides input into final analyses and interpretation including the development of the Clinical Study Report(s) (CSRs), publications and internal/external presentations"
Supports GPCH or Sr CDMD in ensuring overall benefit/risk assessment and monitor safety of the molecule for the assigned section on an ongoing basis and may be a core member of the Safety Management Team (SMT), and supports overall program safety reporting (e.g., Periodic Safety Update Reports (PSURs), Drug Safety Update Reports (DSURs), and other safety related documents) in collaboration with Patient Safety
May be assigned to provide medical input into IDP/CDP and CTP reviews and contributing/driving development of disease clinical standards for new disease areas.
As a medical expert, supports the GPCH or CDH/TAH in interactions with external stakeholders (e.g., regulatory authorities, key opinion leaders, data monitoring boards, advisory boards, patient advocacy groups), internal stakeholders (e.g., CTT, Research, Translational Medicine, Global Medical Affairs, Marketing, HE&OR), and internal decision boards.
As the medical/clinical lead interacts with and represents Novartis to global key opinion leaders and experts and may lead or co-chair steering committees for defined clinical trials or section of a clinical development program
May work with Biomedical Research/Translational Medical Sciences to drive transition of pre-PoC (Proof of Concept) projects to DDP (Development Decision Point) and with BD&L (Business Development & Licensing) including target identification and due diligences together with other medical matters, as assigned by the CDH
Ensures career development of Program reports and other clinical colleagues through active participation in the performance management and talent planning processes. Provides on-boarding, training, & mentoring support
Contributes to medical/scientific training of relevant Novartis stakeholders on the disease area and compound/molecule. May serve as speaker for franchise medical/scientific training
May serve on or lead global initiatives (e.g., process improvement, training, SOP development, other Clinical Development line function initiatives)
May be assigned to lead clinical trial(s) as Clinical Scientific Lead and provide leadership and guidance for all clinical aspects of a clinical trial.